PCMG 2019 Annual General Meeting€¦ · AGM Agenda 1. 2018 Performance vs. Objectives 2. 2019...

PCMG 2019Annual General Meeting Listening carefully and shouting louder….

AGM Agenda

1. 2018 Performance vs. Objectives2. 2019 Mission, Key Objectives and Activities3. Member Voting

3.1 New Committee members3.2 Re-Election of Directors3.3 Treasurer’s Report3.4 AGM report

07/02/2019 © Pharmaceutical Contract Management Ltd. 2019 www.pcmg.org.uk 2

PCMG is the industry’s only organisation dedicated to serving the clinical outsourcing community.

Led by members for members, we develop and share best practice for the procurement and management of

outsourced R&D services.

PCMG Mission Update


Presenter

Presentation Notes

A reminder of our mission and position.

1. 2018 PERFORMANCE VS. OBJECTIVESPCMG AGM 2019


2018 Objective I:Organisational Effectiveness


Refocus on core values

Maintenance of Committee membership and geographic diversityRevision of Mission Statement encompassing ‘Procurement’ membership

New members Membership continues to riseBiotech membership remains an opportunity

Marketing & Communications

Focus on LinkedIn mediaSelection of external resourceFinalisation of new Website

Presenter

Presentation Notes

PCMG objectives are split into three categories: Organisational (how we manage the association), Value (what we deliver for the membership), Financial (ensuring we use the members’ subscriptions and other income wisely for the benefit of members and continuity of the business).

2018 Objective I. Organisational Effectiveness: Committee Stability


• Committee stable (11) after one step-down in 2018• Broad representation including Clinical Ops perspective• Effective sub-team allocation e.g. Workshops & Conference

Our thanks to all the Committee!

Richard Scaife (D), ChairLan BandaraDavid Davies (D), Antje Hindahl (D)Gill Slater, Vice-Chair (D)Susan Tio Gaillard (Stepped down Sept.)

Thierry EscudierRikke WintherSandra JohnsonPia Sauer Larsen SecretaryStacey Fergusson TreasurerDorothee Walter


0

20

40

60

80

100

120

2015 2016 2017 2018

Mem

bers

Year

130

Corporate Membership Strategy Continues to Support Broad Member Base

Membership fee remains frozen @ £450 + VAT (individual)

122 116 99

Expanded to 4+4 in 201610 Corporate MembersNow = 61% total

30 other Pharma/Biotechcompanies listed

2018 Objective I. Organisational Effectiveness: Increase Membership

Presenter

Presentation Notes

The key comment for our recruitment of members is the success of the corporate membership steadily adding the numbers that make PCMG viable.

Cttee. resource increasingly limited:• External writer resource #1 tested

o (Too)High quality

• Developing external writer resource• Linkedin continues to be main channel outside

of emails

2018 Objective I. Organisational Effectiveness:COMMUNICATION


Presenter

Presentation Notes

With the limited (voluntary) resource of the committee, we have looked to external resource to support communication, switching to an alternative mid-2018.

THE NEW WEBSITE!• Committee resource

constraints overcome

• Essential to get it right!

• Accessible, flexible, industry-standard platform

2018 Objective I. Organisational Effectiveness:COMMUNICATION


Presenter

Presentation Notes

It has long been recognised that the PCMG website was not user-friendly and infrequently used. We have worked hard to produce a much-improved ‘shop window’ to increase communication and share the activities and value of PCMG for its members. This went live on 07 February 2019. This will be an ongoing project to maintain and improve content.

2018 Objective II: Value for Members


Workshops 2 EU Workshops: 48 Attendees (April replaced by Webinar)

Training 31 outsourcing professionals attended Outsourcing Essentials Course April: 17 trainees, October: 14 trainees

Webinars New Workshop and Webinar sub-group formed – 2 new webinars in November

Tools & Templates Industry Templates reviewed – update underway

Q&A Forum Remains a unique access to combined knowledge of the membership

Special Groups Site contracting group?

Presenter

Presentation Notes

The Committee continued to deliver on it’s goals for 2018 including launching the newly accredited training course which was full for the first April session, resulting in another session in October. No special interest groups were launched in 2019 but discussions are underway regarding potential options.

A Continuous Improvement Approach since training was re-launched in 2015 after revision of original materials.• 3-Star Accreditation achieved in collaboration with

IAOCRo 10 Learning Outcomes + 21 Assessment Criteria defined

• New course in April 2018 – Oversubscribed! (n=17)• Repeated in October 2018 (n=14)Open to CROs as well as Pharma/Biotech

Highlight: PCMG ESSENTIALS TRAINING


Presenter

Presentation Notes

The relationship with the IAOCR is a significant step for PCMG, aligning with this commercial group that have focused on introducing competency based training standards, mainly with CROs but also with Pharma companies. This aligns well with PCMG mantra to apply best practice to the workplace. Initial discussions on improving CRO CV standards quickly evolved into PCMG agreeing to fund IAOCR to use their experience in gaining accreditation for the Outsourcing Essentials training course. The limited response to the scheduled October course proved the need for this initiative and has, thanks to the hard work of all involved, resulted in the scheduling of a revised, competency structured course that is currently awaiting accreditation. This project reflects PCMGs commitment to support not just the membership but the credibility and role of Outsourcing as a Function within Clinical Development as a whole.

Highlight: 2018 Annual Conference, Malta


‘

Highlight: 2018 Annual Conference, Malta


‘

• Attendees: 192 (vs.179)

• Speakers: 25• Sessions: 15We still lead a very competitive marketplace

“Remains best conference of the year. Ratio of pharma / provider is excellent, especially when connected to absence of commercial stands.”

“..a fantastic networking event, it is well organised, with good content and excellent speakers.”

Conference success continues on content and commercial measures

Presenter

Presentation Notes

Another highly successful conference was completed in a new venue for PCMG with an increase in delegate numbers vs 2017.

2018: STABILITY IN A COMPETITIVE ENVIRONMENT(DRAFT ACCOUNTS 01 JAN 2018 TO 31 DEC 2018)

Treasurers Report


Presenter

Presentation Notes

These are DRAFT accounts, not yet fully reconciled and therefore should not be taken as final and audited. Presented here to give more meaning to the AGM and give members the chance to interrogate the figures and therefore to achieve comfort that company is being run effectively and in the best interests of the membership. My informal comment is that the Directors, the Officers and Committee are doing an exceptionally good job and to highlight that we are all volunteers working for PCMG in spare time and borrowed work time. Have examined previous year’s draft figures versus the final, audited accounts and barring a couple of line items the differences are insignificant and therefore the principle points that I will discuss today will be consistent with the principles reflected in the final accounts.

2018 total income & expenditure

• Total Income £ 239,720 (£ 224,682)+6.7%

• Total Expenditure £ 222,202 (£ 237,833)-6.6%

• Total Profit/Loss £ 17,517 (£ -11,002)

Figures in brackets are for the financial year 2017


Presenter

Presentation Notes

2018 was a positive year for PCMG, with income up and expenditure down (more details in subsequent slides). Overall we have achieved a budgetary surplus of £17,517 which is a good result for the year and has turned around the deficit observed at the end of 2017. As we are a not-for-profit organisation, this provides comfort that there is money available in the bank to spend for the benefit of the membership – If there are worthwhile opportunities to do so, we should invest in order to provide tangible outputs for the membership.

2018 membership income & expenditure

• Membership Income £ 39,300 (£ 37,200)(+5%)

• Membership Expenditure £ 74,725 (£70,123)(+6.6%)

• Net Contribution -£35,425 (-£ 32,923)


Presenter

Presentation Notes

Membership income was up 5% in 2018 as discussed earlier in Richard’s slides. Expenditure was also up vs 2017, as we committed to spending money on the new website (to be launched during AGM!) and in the Outsourcing Essentials training course, including accreditation of that course. Both of those initiatives totalled a cost of £17k which was a worthwhile investment and provided tangible benefits to the membership.

2018 Event Income and Expenditure

• Event Income £ 196,354 (£ 187,502)(+4.7%)

• Event Expenditure £ 147,477 (£ 167,710)(-12%)

• Net Contribution £ 48,877 (£ 19,993)

2017 figure in brackets07/02/2019 © Pharmaceutical Contract Management Ltd. 2019 www.pcmg.org.uk 17

Presenter

Presentation Notes

Event income was increased almost 5% versus 2017, notably with the Outsourcing Essentials training course contributing £13k – This is great for PCMG (the course paid for itself and the accreditation) and shows that the course is valuable and expenditure as such was justified. By choosing the Annual Conference location wisely, we incurred lower expenditure than 2017 which turned into an increased contribution for 2018.

5-year profit/loss


-20000

-10000

0

10000

20000

30000

40000

50000

60000

2014 2015 2016 2017 2018

-413

54501

42734

-1100217517Su

rplu

s / D

efic

it

Year

Presenter

Presentation Notes

2018 year end figures show reversal of 2017 deficit

5 year closing bank balance


0

50000

100000

150000

200000

250000

300000

2014 2015 2016 2017 2018

158090 185642

230802214954

254076

CLO

SIN

G B

ANK

ALAN

CE

YEAR

Presenter

Presentation Notes

2018 closing balance is £254,076 (versus £214954 at year end 2017). Shows that accounts are healthy and that we can support measured spending on well-justified initiatives to continue to make PCMG valuable to the Outsourcing community.

2: 2019 Key Objectives and Strategy


1. Committee Resource for all activities2. Communication & profile

o Harnessing website and other channels

3. Continue membership growth – maintain Corporate Membership

4. Managing relationship with suppliers

2019 Challenges for PCMG


Presenter

Presentation Notes

Following the PCMG Committee and Directors strategy meeting on 6th Feb 2019, challenges and actions were mapped out for the coming year and beyond.

2019 PCMG Strategy Summary


I. Organisational Effectiveness

• Fresh approach to small Biotech members• Retain focus on Corporate membership• Maintain shared workload (project teams)• Continuous improvement of new website

II. Value for Members

• Extension of Associate Membership• Focus on Webinars• Advanced training course

III. Financial Stability

• Continue to invest & manage risk• Attract new members• Manage conference attendance & sponsorship

Presenter

Presentation Notes

Organisational Effectiveness After considering the potential in US and Asia/Japan the Committee decided to revisit the goal of recruiting associate and full members from the growing number of Biotech companies who are progressing more clinical programs into Phase II and beyond, with Project Managers often being expected to manage outsourcing with minimal experience or training. II. Value for members The associate membership level will be an ideal vehicle for the BioTech companies entry into the PCMG world, with Webinars a key tool to help connect and educate this group and ideally lead to full membership and attendance at the training course and other events. III. Financial Stability The key risk for PCMG remains unforeseen last minute cancellation of the Annual Conference due to the sums involved in running the event and the cost of insurance being prohibitive. We maintain a cash reserve to ensure PCMG’s continuity in this worst case scenario whilst also investing in activities.

Organisational Effectiveness2019 Committee Members

07/02/2019

Richard Scaife (D), ChairLan BandaraDavid Davies (D), TreasurerAntje Hindahl (D)Gill Slater, Vice-Chair (D)

Rikke Winther Sandra JohnsonPia Sauer Larsen SecretaryDorothee WalterOlena Goloborodko NewLaura Lulli New

Stepped down for 2019:Thierry Escudier Susan Tio GaillardStacey Fergusson

© Pharmaceutical Contract Management Ltd. 2019 www.pcmg.org.uk 23

(D= Director)

Note: Steve Martindill (ex-Committee) remains Director

Presenter

Presentation Notes

Unfortunately we have to bid farewell from the Committee to three of our members due to changing roles and responsibilities in their ‘day jobs’. We all owe them our gratitude for their selfless support of PCMG over their time on the Committee.

PCMG Annual Conference 2019Sitges, Barcelona, Spain June 5-7


7 C’s of Outsourcing:Sessions Include:

• Managing Pharma & CRO consolidation & expansion• Effective collaboration with Academia• Balancing patient centricity and CRO performance• Big Data – Great Expectations• Medical Device Development• The ‘B’ word… what has and hasn’t happened• Outsourcing clinical studies in Japan

…..and more

Presenter

Presentation Notes

We are pleased to report that thanks to the work of the Steering Committee, the 2019 conference is further advanced than ever before in terms of program and speaker finalisation.

NEXT WORKSHOP: GDPR – 1 YEAR ON


Tues. APRIL 2ND

COPENHAGEN

Presenter

Presentation Notes

With the next workshop planned in Copenhagen.

VOTING FOR/AGAINST MOTIONS PROPOSED BY THE COMMITTEE

PCMG Membership


• Director votes do not count towards 10% quorum.• Only PCMG members can vote. Delegated attendees

cannot vote.• Proxy votes by non-attending members have been

collected.

Voting Rules


1. Committee MembersMotion: To elect new Committee Members andre-elect Committee Members after two years


NewLaura Lulli (GSK)Olena Goloborodko (Celgene)Re-ElectPia Sauer Larsen (Novo)Sandra Johnson (MMV)

Motion PASSED unanimously17 votes vs. 13 Quorum

2. PCM Ltd. Directors

Motion: To re-elect Directors (every 3 years)


Richard Scaife (ind.)Antje Hindahl (ind.)David Davies (ind.)Steve Martindill (Gilead)


• Motion: To approve the Treasurer’s AGM report for Jan-Dec 2018 (based on latest unaudited accountant reports)

3. Treasurer’s Report



• Motion: To approve the Chairman, Directors and Officers’ 2018 report presented at AGM Feb 7th

2019

4. AGM Report



AOB


Presenter

Presentation Notes

C

AGM Meeting Closed


Date post:	22-Aug-2020
Category:	Documents
Upload:	others
View:	0 times
Download:	0 times

PCMG 2019 Annual General Meeting€¦ · AGM Agenda 1. 2018 Performance vs. Objectives 2. 2019...

Documents